Roubaix Capital
Roubaix Capital reported 50 stocks worth $279M in its 13F filing for Q2 2026, filed Aug 10, 2026. Its largest holdings are SXT (3.7%), TKNO (3.2%) and Biolife Solutions Inc (3.1%). Compared with Q1 2026, the fund opened new positions in ATS, OMCL and PRSU, added to SXT, AGYS and DORM, trimmed TKNO, RAL and PKE and sold out of YSS, SARO and RGEN.
Holdings
| # | Stock | Value | Weight | Shares | Change | Shares, 8 qtrs | Held |
|---|---|---|---|---|---|---|---|
| 1 |  SXT Sensient Technologies Corp | $10.4M | 3.7% | 84K | +1,113 (+1%) | 5 of 8 | |
| 2 |  TKNO Alpha Teknova Inc | $9M | 3.2% | 1.6M | −303K (−16%) | 7 of 8 | |
| 3 | BIOLIFE SOLUTIONS INC | $8.7M | 3.1% | 310K | New position | 1 of 8 | |
| 4 |  AGYS Agilysys Inc | $8.1M | 2.9% | 77K | +1,535 (+2%) | 6 of 8 | |
| 5 |  DORM Dorman Prods Inc | $7.6M | 2.7% | 56K | +13K (+30%) | 3 of 8 | |
| 6 |  RAL Ralliant Corp | $7.5M | 2.7% | 102K | −53K (−34%) | 4 of 8 | |
| 7 |  STVN Stevanato Group S P A | $7.2M | 2.6% | 397K | +12K (+3%) | 3 of 8 | |
| 8 |  ATS Ats Corporation | $7.1M | 2.5% | 247K | New position | 2 of 8 | |
| 9 |  OMCL Omnicell Com | $7M | 2.5% | 168K | New position | 5 of 8 | |
| 10 |  PRSU Pursuit Attractions and Hosp | $6.9M | 2.5% | 123K | New position | 2 of 8 |
Positions at Jun 30, 2026, as reported. Change is against the fund's Q1 2026 filing; weight is the share of the fund's reported stocks.
Sold out
held in Q1 2026, gone in Q2 2026| Stock | Value last quarter | Shares sold |
|---|---|---|
 YSS York Space Systems Inc | $8.5M | 383K |
 SARO Standardaero Inc | $7.6M | 294K |
 RGEN Repligen Corp | $6.4M | 55K |
 MLAB Mesa Labs Inc | $6.4M | 72K |
 TRNS Transcat Inc | $6.2M | 85K |
🔒 Free account: see all 21.
Reported value
last 8 quartersThe value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.
Filings for Q2 2026
straight from the SEC| Filed | Form | Quarter | |
|---|---|---|---|
| Aug 10, 2026 | 13F-HR | Q2 2026 | SEC filing ↗ |
Other superinvestors
All hedge fund holdings →Roubaix Capital 13F FAQ
What does Roubaix Capital own?
Roubaix Capital reported 50 stocks worth $279M in its 13F filing for Q2 2026, filed Aug 10, 2026. Its largest holdings are SXT (3.7%), TKNO (3.2%) and Biolife Solutions Inc (3.1%). The table above lists every position in the filing (the top 10 without an account).
What did Roubaix Capital buy and sell in Q2 2026?
Compared with Q1 2026: 28 new positions, 12 added to, 10 trimmed and 21 sold out. New positions include ATS, OMCL and PRSU. It sold all of YSS, SARO and RGEN.
When will Roubaix Capital file its next 13F?
Holdings as of Sep 30, 2026 are due by Nov 16, 2026. The filing appears on this page within minutes of reaching the SEC.
How much is Roubaix Capital's portfolio worth?
The Q2 2026 filing reports $279M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.